Zobrazeno 1 - 10
of 14
pro vyhledávání: '"TAKAHISA SHIRAHAMA"'
Autor:
DAISUKE MUROYA, HIROTOSHI TSURU, HISAAKI SHIMOKOBE, YUICHI NAGAO, YASUNORI YOSHIMOTO, YOSHITO WADA, KOUJI HAYASHI, SATOSHI TANIWAKI, RYUTA MIDORIKAWA, SHINICHI TANIWAKI, SATOKI KOJIMA, SHOICHIRO ARAI, TAKAHISA SHIRAHAMA, YUICHI GOTO, HISAMUNE SAKAI, MUNEHIRO YOSHITOMI, TORU HISAKA, YOSHITO AKAGI, KOJI OKUDA
Publikováno v:
Anticancer research. 42(8)
Malignant biliary obstruction (MBO) is a life-threatening condition. We aimed to investigate the outcome of salvage percutaneous transhepatic biliary drainage (PTBD) in patients with unresectable MBO due to failure of management by endoscopic retrogr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2a5efb634c67e479209548e39e7893a
https://pubmed.ncbi.nlm.nih.gov/35896223
https://pubmed.ncbi.nlm.nih.gov/35896223
Autor:
Munehiro, Yoshitomi, Ryuichi, Kawahara, Shinichi, Taniwaki, Ryuta, Midorikawa, Satoki, Kojima, Daisuke, Muroya, Shoichiro, Arai, Takahisa, Shirahama, Hiroki, Kanno, Shogo, Fukutomi, Yuichi, Goto, Yoriko, Nomura, Masanori, Akashi, Toshihiro, Sato, Hisamune, Sakai, Toru, Hisaka, Yoshito, Akagi
Publikováno v:
Medicine. 101:e29048
Percutaneous drainage catheters (PDCs) are required for the management of benign biliary strictures refractory to first-line endoscopic treatment. While biliary patency after PDC placement exceeds 75%, long-term catheterization is occasionally necess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::160b74f20fcb455f2b95c1ecd54650a7
https://doi.org/10.1097/md.0000000000029048
https://doi.org/10.1097/md.0000000000029048
Autor:
Kyogo Itoh, Takahisa Shirahama, Tetsuro Sasada, Akira Yamada, Michi Morita, Daisuke Muroya, Rin Yamaguchi, Satoko Matsueda, Shigeki Shichijo, Shigeru Yutani
Publikováno v:
Cancer Science
Overall survival of patients with hepatocellular carcinoma (HCC) refractory to locoregional therapy is dismal, even following treatment with sorafenib, a multikinase inhibitor. To develop a more efficacious treatment, we undertook a feasibility study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60fd8c6266a0a91d8d8395aa287e8ca2
https://doi.org/10.1111/cas.13301
https://doi.org/10.1111/cas.13301
Autor:
Masayasu Naito, Takahisa Shirahama, Koji Okuda, Tetsuro Sasada, Satoko Matsueda, Takuto Yamashita, Daisuke Muroya, Kyogo Itoh, Shigeki Shichijo, Akira Yamada, Shinjiro Sakamoto, Shigeru Yutani
Publikováno v:
Cancer Science
Since the prognosis of advanced biliary tract cancer (aBTC) still remains very poor, new therapeutic approaches, including immunotherapies, need to be developed. In the current study, we conducted an open-label randomized phase II study to test wheth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9541e7306e5a811ae676ec80d6a74d29
https://doi.org/10.1111/cas.13193
https://doi.org/10.1111/cas.13193
Autor:
Nobuhisa Shirahama, Yuichi Goto, Koji Okuda, Masanori Akashi, Hiroyuki Tanaka, Yuichirou Maruyama, Daisuke Muroya, Takahisa Shirahama, Shogo Fukutomi, Hiroyuki Horiuchi, Shyoichirou Arai, Hisamune Sakai, Ryuichi Kawahara, Hiroto Ishikawa, Masafumi Yasunaga, Yoriko Nomura, Toru Hisaka, Yoshito Akagi, Katsuaki Takagi
Publikováno v:
The Kurume medical journal. 63(1.2)
T2 (tumor invades perimuscular connective tissue; no extension beyond serosa or into liver) gallbladder cancer has generally been treated by S4aS5 subsegmentectomy (S4aS5 HR). We investigated the therapeutic effect of full-thickness cholecystectomy (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62fe221e82767365ee1f2c5a9ddd28ed
https://pubmed.ncbi.nlm.nih.gov/28331137
https://pubmed.ncbi.nlm.nih.gov/28331137
Autor:
Takahisa Shirahama, Tetsuro Sasada, Munehiro Yoshitomi, Shigeru Yutani, Akira Yamada, Kyogo Itoh, Ryuji Takahashi, Masanori Noguchi
Publikováno v:
Human Vaccines & Immunotherapeutics. 9:1069-1072
Biliary tract cancer (BTC) is one of the most aggressive malignancies. Although various promising regimens of chemotherapeutic and/or molecular targeted agents have been developed, further treatment modalities, including immunotherapies, still remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b75f9b8828bae1254c287257b2acf935
https://doi.org/10.4161/hv.23844
https://doi.org/10.4161/hv.23844
Autor:
Shigeru Yutani, Munehiro Yoshitomi, Satoko Matsueda, Akira Yamada, Takahisa Shirahama, Tetsuro Sasada, Nobukazu Komatsu, Kyogo Itoh
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2013 (2013)
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-based Complementary and Alternative Medicine : eCAM
Juzentaihoto (JTT) is a well-known Japanese herbal medicine, which has been reported to modulate immune responses and enhance antitumor immunity in animal models. However, it is not clear whether JTT has similar effects on humans. In particular, ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8330e7e24c933c73eee4b578fa6b029
https://doi.org/10.1155/2013/981717
https://doi.org/10.1155/2013/981717
Autor:
Ryuichi, Kawahara, Masahiko, Tanigawa, Hiroyuki, Horiuchi, Kenjiro, Takahashi, Takahisa, Shirahama, Youhei, Nakama, Hiroaki, Takagi, Yusuke, Hirakawa, Yuichiro, Maruyama, Hisamune, Sakai, Hiroto, Ishikawa, Toru, Hisaka, Masashi, Yasunaga, Koji, Okuda
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 41(12)
When surgery is selected to treat postoperative recurrent hilar cholangiocarcinoma in the intrapancreatic bile duct, attention should be paid to the following: 1 ) technical resectability of the lesion, 2) reconstruction, and 3) high risk of complica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e444799be3e849e047301704f2c62ee
https://pubmed.ncbi.nlm.nih.gov/25731238
https://pubmed.ncbi.nlm.nih.gov/25731238
Autor:
Ryuji Takahashi, Munehiro Yoshitomi, Shigeru Yutani, Takahisa Shirahama, Masanori Noguchi, Akira Yamada, Kyogo Itoh, Tetsuro Sasada
Publikováno v:
Human Vaccines & Immunotherapeutics; May2013, Vol. 9 Issue 5, p1069-1072, 4p
Autor:
Yoshihiro Uchino, Takahisa Shirahama, Yuhei Kitasato, Yoshito Akagi, Kazumitsu Kiyomatsu, Shuko Saku, Ryuta Midorikawa, Hiroyuki Tanaka, Taizan Minami, Koji Okuda
Publikováno v:
Surgical Case Reports
A 63-year-old man, who had undergone total gastrectomy and Roux-en-Y reconstruction for gastric cancer 10 years previously, was admitted to our hospital with complaints of abdominal pain, palpable abdominal tumor, and hematemesis. On admission, the a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ca2c29e81d17d151236c01a35e4ec37